TECLens Secures $9.3 Million Series A Funding to Advance Its Non-Invasive Refractive Technology
February 11, 2025 09:03 AM Eastern Standard Time STAMFORD, Conn.–(BUSINESS WIRE)–TECLens, Inc., a clinical-stage ophthalmic medical device company, announced today it raised $9.3 million in a Series A round co-led by Johnson & Johnson Innovation…